Ameriprise’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-124,600
| Closed | -$3.57M | – | 3841 |
|
|
2018
Q4 | $3.57M | Sell |
124,600
-62,450
| -33% | -$1.77M | ﹤0.01% | 2340 |
|
|
2018
Q3 | $5.22M | Sell |
187,050
-23,679
| -11% | -$666K | ﹤0.01% | 2311 |
|
|
2018
Q2 | $5.88M | Buy |
210,729
+15,525
| +8% | +$416K | ﹤0.01% | 2136 |
|
|
2018
Q1 | $4.85M | Buy |
195,204
+67,971
| +53% | +$1.65M | ﹤0.01% | 2199 |
|
|
2017
Q4 | $3.08M | Sell |
127,233
-4,293
| -3% | -$113K | ﹤0.01% | 2433 |
|
|
2017
Q3 | $3.63M | Sell |
131,526
-7,605
| -5% | -$203K | ﹤0.01% | 2306 |
|
|
2017
Q2 | $3.49M | Sell |
139,131
-5,626
| -4% | -$139K | ﹤0.01% | 2321 |
|
|
2017
Q1 | $3.88M | Sell |
144,757
-27,110
| -16% | -$749K | ﹤0.01% | 2228 |
|
|
2016
Q4 | $4.5M | Sell |
171,867
-113,938
| -40% | -$2.82M | ﹤0.01% | 2124 |
|
|
2016
Q3 | $7.14M | Sell |
285,805
-47,121
| -14% | -$1.1M | ﹤0.01% | 1716 |
|
|
2016
Q2 | $7.22M | Sell |
332,926
-31,536
| -9% | -$563K | ﹤0.01% | 1660 |
|
|
2016
Q1 | $5.46M | Sell |
364,462
-29,236
| -7% | -$490K | ﹤0.01% | 1889 |
|
|
2015
Q4 | $8.63M | Buy |
393,698
+117,117
| +42% | +$2.18M | 0.01% | 1560 |
|
|
2015
Q3 | $4.36M | Buy |
276,581
+122,935
| +80% | +$1.97M | ﹤0.01% | 2109 |
|
|
2015
Q2 | $2.18M | Buy |
153,646
+59,299
| +63% | +$1M | ﹤0.01% | 2701 |
|
|
2015
Q1 | $1.63M | Buy |
94,347
+25,750
| +38% | +$455K | ﹤0.01% | 2684 |
|
|
2014
Q4 | $1.23M | Buy |
68,597
+590
| +0.9% | +$9.5K | ﹤0.01% | 2775 |
|
|
2014
Q3 | $893K | Hold |
68,007
| – | – | ﹤0.01% | 2854 |
|
|
2014
Q2 | $977K | Sell |
68,007
-218,850
| -76% | -$2.86M | ﹤0.01% | 2781 |
|
|
2014
Q1 | $3.65M | Buy |
286,857
+185,560
| +183% | +$2.42M | ﹤0.01% | 2224 |
|
|
2013
Q4 | $1.01M | Sell |
101,297
-1,291,107
| -93% | -$14.7M | ﹤0.01% | 2659 |
|
|
2013
Q3 | $18.3M | Buy |
1,392,404
+210,458
| +18% | +$2.76M | 0.01% | 1043 |
|
|
2013
Q2 | $16.9M | Buy |
+1,181,946
| New | +$14.9M | 0.01% | 1078 |
|
Other funds holding NXTM
Ameriprise's NXTM Position: Q1 2019 in Review
Ameriprise sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 124,600 shares — an estimated $3.57M sold.
Ameriprise first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $18.3M in Q3 2013. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- Ameriprise reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- Ameriprise sold 124,600 NxStage Medical Inc. shares in Q1 2019, an estimated $3.57M.
- Ameriprise first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
- Ameriprise's NxStage Medical Inc. position peaked at $18.3M in Q3 2013.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on Ameriprise's 13F filing for Q1 2019, filed 15 May 2019.